How many institutions held INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value in Q3 2023?

16 institutional investors reported INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value for Q3 2023. Use the holders table for investor-level position and value details.

Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP)

Q: What does CUSIP 45339J105 represent in this 13F holders report?

CUSIP 45339J105 is the security identifier for INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

CUSIP: 45339J105

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, $0.01 par value
Shares outstanding: 113,183,288
Total 13F shares: 570,529
Share change: -13,211
Total reported value: $1,569,014
Price per share: $2.76
Number of holders: 16
Value change: -$25,658
Number of buys: 7
Number of sells: 5

Security key

45339J105

Report period

Q3 2023

Institutions

Top holders

INDP full security history Newer quarter: Q4 2023 Previous quarter: Q2 2023 Indaptus Therapeutics, Inc. SEC filings Indaptus Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 45339J105

Newer quarter: Q4 2023 Previous quarter: Q2 2023

Recent filing periods:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	0.22%	250,348	$478,165	—	30 Jun 2023	13F
INVESTMENT HOUSE LLC	13F	Company	0.1%	108,282	$206,819	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	50,521	$92,453	—	30 Jun 2023	13F
STRATEGY ASSET MANAGERS LLC	13F	Company	0.04%	45,336	$86,592	—	30 Jun 2023	13F
Pine Valley Investments Ltd Liability Co	13F	Company	0.04%	44,420	$84,843	—	30 Jun 2023	13F
Vivaldi Capital Management LP	13F	Company	0.02%	24,000	$45,840	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.02%	20,800	$40,000	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	0.02%	19,473	$35,636	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.01%	12,918	$24,673	—	30 Jun 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	5,665	$10,820	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0%	829	$1,583	—	30 Jun 2023	13F
UBS Group AG	13F	Company	0%	640	$1,222	—	30 Jun 2023	13F
Bangor Savings Bank	13F	Company	0%	400	$764	—	30 Jun 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	101	$193	—	30 Jun 2023	13F
GROUP ONE TRADING LLC	13F	Company	0%	7	$13	—	30 Jun 2023	13F
Glen R. Anderson	3/4/5	10%+ Owner	— class O/S missing	1,190,400	$2,785,536	—	10 Aug 2023	3/4/5
Hoonmo Lee	3/4/5	Director	— mixed-class rows	708,272 mixed-class rows	$1,626,157	—	04 Aug 2021	3/4/5
Boyan Vesselinov Litchev	3/4/5	Chief Medical Officer	— class O/S missing	1,150	$2,691	—	01 Feb 2022	3/4/5
Brian O'Callaghan	3/4/5	Director	— class O/S missing	13,750	$976	—	30 Sep 2022	3/4/5

Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) as of Q3 2023

As of 30 Sep 2023, Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 570,529 shares. The largest 10 holders included VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, Pine Valley Investments Ltd Liability Co, RENAISSANCE TECHNOLOGIES LLC, Vivaldi Capital Management LP, STATE STREET CORP, Tower Research Capital LLC (TRC), and MORGAN STANLEY. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.